Subscribe
Advertise
Acuity Media Network logo
a
M&A
Technology
Regulation
|
Events
About

M

Search Our Professional Healthcare Articles...

a

// News and Events

M&A
Technology
Regulation

Events

// About Acuity Media Network

About

Advertise

Contact

Join Our Newsletter

Acuity Media Network

FDA Premarket Notification (510k) Analysis Articles

Technology
Wave Neuroscience’s MeRT Gains FDA Clearance for Adult PTSD on the First Sham-Controlled Trial in the Category. The 510(k) Summary Details the Trial Results, the Safety Profile, and the Reimbursement Path Ahead.

Wave Neuroscience’s MeRT Gains FDA Clearance for Adult PTSD on the First Sham-Controlled Trial in the Category. The 510(k) Summary Details the Trial Results, the Safety Profile, and the Reimbursement Path Ahead.

Read More
Acuity Media Network Powered by eCap logo

We inform decision-makers, investors, and innovators in behavioral health through an editorially independent platform that delivers sharp insights, sparks strategic thinking, and drives measurable growth for our partners.

About Acuity Media Network

Contact Us

Editorial Standards

// Article Categories

  • M&A
  • Technology
  • Regulation
// Join Our Newsletter
// Advertise

Advertise with Acuity Media Network and reach a larger audience.

Get The Media Kit

Copyright © Acuity Media Network 2026
Privacy Policy   |   Accessibility Statement

X logo LinkedIn logo